United-Guardian is a household & personal products business based in the US. United-Guardian shares (UG) are listed on the NASDAQ and all prices are listed in US Dollars. United-Guardian employs 23 staff and has a trailing 12-month revenue of around $12.3 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $14.05 |
|---|---|
| 52-week range | $5.47 - $15.02 |
| 50-day moving average | $11.23 |
| 200-day moving average | $8.94 |
| Wall St. target price | N/A |
| PE ratio | 20.0845 |
| Dividend yield | $0.6 (4.21%) |
| Earnings per share (TTM) | $0.71 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $14.05 from 2024-09-04
| 1 week (2024-08-29) | -1.61% |
|---|---|
| 1 month (2024-08-05) | 24.78% |
| 3 months (2024-06-05) | 56.46% |
| 6 months (2024-03-05) | 69.48% |
| 1 year (2023-09-05) | 75.84% |
|---|---|
| 2 years (2022-09-02) | -10.22% |
| 3 years (2021-09-03) | 15.56 |
| 5 years (2019-09-05) | 17.213 |
Valuing United-Guardian stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of United-Guardian's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
United-Guardian's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, United-Guardian shares trade at around 20x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
United-Guardian's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.8 million.
The EBITDA is a measure of a United-Guardian's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $12.3 million |
|---|---|
| Operating margin TTM | 32.88% |
| Gross profit TTM | $6.7 million |
| Return on assets TTM | 17.77% |
| Return on equity TTM | 28.72% |
| Profit margin | 26.37% |
| Book value | $2.64 |
| Market Capitalization | $65.5 million |
TTM: trailing 12 months
Dividend payout ratio: 84.51% of net profits
Recently United-Guardian has paid out, on average, around 84.51% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), United-Guardian shareholders could enjoy a 4.21% return on their shares, in the form of dividend payments. In United-Guardian's case, that would currently equate to about $0.6 per share.
United-Guardian's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
United-Guardian's most recent dividend payout was on 30 July 2024. The latest dividend was paid out to all shareholders who bought their shares by 22 July 2024 (the "ex-dividend date").
United-Guardian's shares were split on a 6:5 basis on 11 September 1985. So if you had owned 5 shares the day before before the split, the next day you'd have owned 6 shares. This wouldn't directly have changed the overall worth of your United-Guardian shares – just the quantity. However, indirectly, the new 16.7% lower share price could have impacted the market appetite for United-Guardian shares which in turn could have impacted United-Guardian's share price.
Over the last 12 months, United-Guardian's shares have ranged in value from as little as $5.4694 up to $15.02. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while United-Guardian's is 0.787. This would suggest that United-Guardian's shares are less volatile than average (for this exchange).
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc.
Use this calculator to quickly see potential outcomes of your options trades.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.